Tel.: 514-340-8222 ext. 28575
Marc Fabian, PhD
Investigator, Lady Davis Institute
Associate Professor, Departments of Oncology and Biochemistry, McGill University
Dr. Fabian's Publications Indexed on PubMed

Marc Fabian obtained his Ph.D. from York University, Toronto, Canada. He completed post-doctoral training with Dr. Nahum Sonenberg (McGill University) where he investigated how microRNAs post-transcriptionally regulate gene expression. Specifically, he focused on investigating how microRNAs inhibit the translation and subsequently promote the degradation of target mRNAs. In 2013, he joined the Lady Davis Institute as an independent investigator and obtained an Assistant Professor position in the Department of Oncology, McGill University.
Major Research Activities
Post-transcriptional control (PTC) programs regulate protein production after a messenger (m) RNA is transcribed from its DNA template. Many PTC programs control protein production by repressing mRNA translation and/or initiating mRNA destabilization, events collectively referred to as ‘silencing’. These programs are in general mediated by RNA binding proteins and ribonucleoprotein complexes that are recruited to specific mRNAs in order to engender silencing. Given their pervasive use, it is not surprising that many human cancers, as well as many other disorders, are associated with defects in gene silencing networks.

The overall theme of my research program is to investigate how microRNAs, RNA binding proteins and ribonucleoprotein complexes translationally repress and/or destabilize target mRNAs in mammalian cells. Ultimately, we wish to use this knowledge to develop new biotechnologies and to identify how aberrant post-transcriptional regulation of gene expression is linked to human disease.

Recent Publications
Choquet K, Forget D, Meloche E, Dicaire MJ, Bernard G, Vanderver A, Schiffmann R, Fabian MR, Teichmann M, Coulombe B, Brais B, Kleinman CL. Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200. J Biol Chem. 2019 Mar 21. pii: jbc.RA118.006271. doi: 10.1074/jbc.RA118.006271
Nishimura T, Fakim H, Brandmann T, Youn JY, Gingras AC, Jinek M, Fabian MRHuman MARF1 is an endoribonuclease that interacts with the DCP1:2 decapping complex and degrades target mRNAs. Nucleic Acids Res. 2018 Dec 14;46(22):12008-12021. doi: 10.1093/nar/gky1011.
Brandmann T, Fakim H (co-first author), Padamsi Z, Youn J-Y, Gingras A-C, Fabian MR* (co-corresponding author) and Jinek M*. Molecular architecture of LSM14 interactions involved in the assembly of mRNA silencing complexes. (2018) The EMBO Journal (in press)

Ji-Young Youn, Wade H. Dunham, Seo Jung Hong, James D.R. Knight, Ginny I. Chen, Halil Bagci, Mikhail Bashkurov, Bhavisha Rathod, Graham MacLeod, Simon W. M. Eng, Stéphane Angers, Quaid Morris, Marc Fabian, Jean-François Côté and Anne-Claude Gingras. High-density proximity mapping reveals the subcellular organization of mRNA associated granules and bodies. (2018) Molecular Cell (in press)

Nishimura T, and MR Fabian. 2016. Scanning for a unified model for translational repression by microRNAs. The EMBO Journal. 35(11):1158-9.

Nishimura, T., Padamsi, Z., Fakim, H., Milette, S., Dunham, W., Gingras, A-C., and Fabian, M.R. (2015). The eIF4E binding protein 4E-T is a component of the mRNA decay machinery that bridges the 5´ and 3´ termini of target mRNAs. Cell Reports 11(9):1425-36.

Important Links

Support research at the Lady Davis Institute - Jewish General Hospital